// App-Quantinova.ai

1262 : Loss‐of‐function mutations in NR4A2 cause dopa‐responsive dystonia-parkinsonism

Researchers

Presenter

  • T. Wirth

Principal Investigators

  • LL. Mariani

  • G. Bergant

  • M. Baulac

  • M.O Habert

  • N. Drouot

  • E. Ollivier

  • A. Hodic

  • G.o Rudolf

  • P. Nitschke

  • G.a Rudolf

  • J. Chelly

  • C. Tranchant

  • M. Anheim

  • E. Roze

Medical Centers

  • N/A

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Parkinson's disease

  • Dystonia

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved